Loading...
XSHE
002014
Market cap1.03bUSD
Dec 05, Last price  
11.84CNY
1D
3.14%
1Q
3.59%
Jan 2017
33.20%
IPO
460.58%
Name

Huangshan Novel Co Ltd

Chart & Performance

D1W1MN
XSHE:002014 chart
P/E
15.50
P/S
2.06
EPS
0.76
Div Yield, %
4.65%
Shrs. gr., 5y
0.58%
Rev. gr., 5y
6.28%
Revenues
3.53b
+4.34%
610,814,223718,899,0701,045,570,7371,219,428,1161,054,575,3421,276,392,2351,513,086,1271,521,013,2031,618,458,0511,668,452,2721,783,867,8011,904,193,7772,008,242,6052,332,267,5452,599,724,0412,737,497,3763,023,694,5513,304,135,2483,378,793,6513,525,459,395
Net income
468m
+14.63%
44,112,19347,255,23153,811,37168,050,165100,690,892121,235,153147,844,170178,770,833176,269,220154,491,070178,539,016202,710,560205,483,203225,324,381269,116,549303,032,141315,913,031362,828,955408,045,340467,752,896
CFO
461m
-10.46%
44,614,29064,806,47983,957,648151,200,923116,261,750125,460,797197,379,903185,638,196117,520,977187,818,118247,696,629280,628,298277,299,915323,833,456428,432,150548,623,540296,233,778543,555,266515,342,436461,455,128
Dividend
Apr 12, 20240.55 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Huangshan Novel Co., Ltd. manufactures and sells packaging materials primarily in China. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials. Its products are used in foodstuff, daily chemicals, pharmaceutical, agrochemicals, electronics, building materials, and other fields. The company also exports its products to Europe, the United States, Mexico, Japan, the Middle East, and rest of Asia. Huangshan Novel Co., Ltd. was founded in 1992 and is based in Huangshan, China.
URL
https://www.novel.com.cn/
IPO date
Jul 08, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT